1. Home
  2. CDXS vs TLS Comparison

CDXS vs TLS Comparison

Compare CDXS & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • TLS
  • Stock Information
  • Founded
  • CDXS 2002
  • TLS 1969
  • Country
  • CDXS United States
  • TLS United States
  • Employees
  • CDXS N/A
  • TLS N/A
  • Industry
  • CDXS Major Chemicals
  • TLS EDP Services
  • Sector
  • CDXS Industrials
  • TLS Technology
  • Exchange
  • CDXS Nasdaq
  • TLS Nasdaq
  • Market Cap
  • CDXS 201.3M
  • TLS 188.7M
  • IPO Year
  • CDXS 2010
  • TLS 2020
  • Fundamental
  • Price
  • CDXS $2.30
  • TLS $2.52
  • Analyst Decision
  • CDXS Buy
  • TLS Buy
  • Analyst Count
  • CDXS 2
  • TLS 6
  • Target Price
  • CDXS $11.00
  • TLS $3.94
  • AVG Volume (30 Days)
  • CDXS 1.0M
  • TLS 1.5M
  • Earning Date
  • CDXS 05-14-2025
  • TLS 05-09-2025
  • Dividend Yield
  • CDXS N/A
  • TLS N/A
  • EPS Growth
  • CDXS N/A
  • TLS N/A
  • EPS
  • CDXS N/A
  • TLS N/A
  • Revenue
  • CDXS $49,815,000.00
  • TLS $109,269,000.00
  • Revenue This Year
  • CDXS $2.41
  • TLS $34.75
  • Revenue Next Year
  • CDXS $34.28
  • TLS $27.91
  • P/E Ratio
  • CDXS N/A
  • TLS N/A
  • Revenue Growth
  • CDXS N/A
  • TLS N/A
  • 52 Week Low
  • CDXS $1.90
  • TLS $1.83
  • 52 Week High
  • CDXS $6.08
  • TLS $5.03
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 44.61
  • TLS 48.14
  • Support Level
  • CDXS $2.30
  • TLS $1.83
  • Resistance Level
  • CDXS $2.56
  • TLS $2.58
  • Average True Range (ATR)
  • CDXS 0.20
  • TLS 0.18
  • MACD
  • CDXS -0.01
  • TLS -0.00
  • Stochastic Oscillator
  • CDXS 46.67
  • TLS 45.68

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: